tiprankstipranks
Terumo (TRUMF)
OTHER OTC:TRUMF

Terumo (TRUMF) Stock Price & Analysis

19 Followers

TRUMF Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$12.43 - $19.92
Previous Close$16.74
Volume1.34K
Average Volume (3M)2.13K
Market Cap
$24.77B
Enterprise Value$25.22B
Total Cash (Recent Filing)¥162.63B
Total Debt (Recent Filing)¥231.71B
Price to Earnings (P/E)35.6
Beta0.85
May 14, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.89%
Share Statistics
EPS (TTM)0.47
Shares OutstandingN/A
10 Day Avg. Volume1,369
30 Day Avg. Volume2,128
Standard Deviation0.07
R-Squared0.25
Alpha-0.00174
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

0.00%0.00%0.02%99.98%
0.00%
Insiders
0.00%
Mutual Funds
0.02% Other Institutional Investors
99.98% Public Companies and
Individual Investors

TRUMF FAQ

What was Terumo’s price range in the past 12 months?
Terumo lowest stock price was $12.43 and its highest was $19.92 in the past 12 months.
    What is Terumo’s market cap?
    Currently, no data Available
    When is Terumo’s upcoming earnings report date?
    Terumo’s upcoming earnings report date is May 14, 2024 which is in 6 days.
      How were Terumo’s earnings last quarter?
      Terumo released its earnings results on Feb 07, 2024. The company reported $0.135 earnings per share for the quarter, beating the consensus estimate of N/A by $0.135.
        Is Terumo overvalued?
        According to Wall Street analysts Terumo’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Terumo pay dividends?
          Terumo does not currently pay dividends.
          What is Terumo’s EPS estimate?
          Terumo’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Terumo have?
          Terumo has 1,490,697,300 shares outstanding.
            What happened to Terumo’s price movement after its last earnings report?
            Terumo reported an EPS of $0.135 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 4.077%.
              Which hedge fund is a major shareholder of Terumo?
              Currently, no hedge funds are holding shares in TRUMF
              ---

              Terumo Stock Smart Score

              N/A
              Not Ranked
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Company Description

              Terumo

              Terumo Corp. engages in the manufacturing and sale of medical products and equipment. It operates through the following segments: Cardiac and Vascular Company, General Hospital Company, and Blood Management Company. The Cardiac and Vascular Company segment offers services and treatments including cardiac and vascular surgery and interventional therapies performed inside blood vessels. The General Hospital Company segment provides infusion and closed anticancer drug infusion systems, measuring devices system with communication functions, diabetes management, adhesion barrier, and peritoneal dialysis. The Blood Management Company segment offers a combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction. The company was founded by Shibasaburo Kitasato on September 17, 1921 and is headquartered in Tokyo, Japan
              ---

              TRUMF Company Deck

              ---

              TRUMF Earnings Call

              Q3 2024
              0:00 / 0:00
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Becton Dickinson
              Abbott Labs
              Baxter International
              Stryker
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis